Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03468487
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
6OC | (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca- 9,12-dienoic acid | A,B | 2VV4 | 0.78 |  |
AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,B,E | 1R8Q | 0.77 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A | 1RE0 | 0.77 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,E | 1S9D | 0.77 | |
6OB | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca- 8,12-dienoic acid | A,B | 2VV4 | 0.74 | |
PG2 | PROSTAGLANDIN D2 | A,B | 1RY0 | 0.9 | |
RCL | RICINOLEIC ACID | A | 2CM4 | 0.74 | |
| RCL | RICINOLEIC ACID | A | 2CM9 | 0.74 | |
| RCL | RICINOLEIC ACID | A | 1FK7 | 0.74 | |
164 | 2-(3-CARBOXYPROPIONYL)-6-HYDROXY- CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID | A | 1R6W | 0.77 | |
OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec- 9-enoate | A | 3D4S | 0.7 | |
OCR | (5E,8E,11Z,13E)-15-oxoicosa-5,8,11,13- tetraenoic acid | A,B | 2ZK4 | 0.7 | |
1NB | 2-(2-HYDROXY-CYCLOPENTYL)-PENT- 4-ENAL | P | 1BRU | 0.74 | |
TH2 | TESTOSTERONE HEMISUCCINATE | A,B | 2CBT | 0.7 | |
| TH2 | TESTOSTERONE HEMISUCCINATE | A,B,C,D,E,F | 2CBQ | 0.7 | |
| TH2 | TESTOSTERONE HEMISUCCINATE | A | 2CBO | 0.7 | |
OPD | 9R,13R-12-OXOPHYTODIENOIC ACID | A,B | 1ICQ | 0.83 | |
ASY | (12E)-10-oxooctadec-12-enoic acid | A,B | 3CEE | 0.7 | |
GR3 | 3-ACETOXY-17-(1-FORMYL-5-METHYL- 3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14- TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE- 4-CARBOXYLIC ACID | B,D | 1AWH | 0.71 | |
PTG | (5E,14E)-11-oxoprosta-5,9,12,14- tetraen-1-oic acid | A,B | 2ZK1 | 0.74 | |
| PTG | (5E,14E)-11-oxoprosta-5,9,12,14- tetraen-1-oic acid | A | 2ZK2 | 0.74 | |
E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL- 4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2HFK | 0.84 | |
PGX | 7-[6-(3-HYDROPEROXY-OCT-1-ENYL)- 2,3-DIOXA-BICYCLO[2.2.1]HEPT-5- YL]-HEPT-5-ENOIC ACID | A,B,C,D | 1DDX | 0.75 | |
8PG | (8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID | A,B | 2G5W | 0.86 | |
NTH | SUCCINIC ACID MONO-(13-METHYL-3- OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN- 17-YL) ESTER | A,B | 1BUQ | 0.71 | |
E2P | PROSTAGLANDIN B2 | A | 1CZ2 | 0.75 | |
5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A | 2ZB4 | 0.96 | |
| 5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A,B | 1V3V | 0.96 | |